| Reata Pharmaceuticals - 2011 Fierce 15 - FierceBiotech |
|
|
FierceBiotech Researchers are recruiting 1600 patients with advanced kidney disease and Type 2 diabetes with an eye to demonstrating that bardoxolone can extend the amount of time they can live without being forced onto dialysis. A distinct advantage is that |